Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Nelson

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Heliyon|June 5, 2018
The preparation of benzyl esters using stoichiometric niobium (V) chloride versus niobium grafted SiO<sub>2</sub> catalyst: A comparison studySandro L Barbosa, Camila D Lima, Melina A R Almeida, et al.
Cell Reports|December 3, 2014
FXR1P limits long-term memory, long-lasting synaptic potentiation, and de novo GluA2 translationDenise Cook, Erin Nuro, Emma V Jones, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
American Journal of Medical Genetics. Part A|May 17, 2007
Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardationFrank J Probst, Elizabeth R Roeder, Victoria B Enciso, et al.
Journal of Food Science|March 11, 2022
Polycyclic aromatic hydrocarbons in cachaças packed in bottles of polyethylene terephthalateRafaella H Z Souza, Maria das Graças Cardoso, Ana Maria R Machado, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 17, 2009
In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268)Matthew J Fell, Kenneth W Perry, Julie F Falcone, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT(1A) receptor antagonism/SSRI activities. Part 2Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
Neurobiology of Disease|February 15, 2011
AFQ056, a new mGluR5 antagonist for treatment of fragile X syndromeJosien Levenga, Shigemi Hayashi, Femke M S de Vrij, et al.
The International Journal of Neuropsychopharmacology|June 24, 2010
Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in ratsJorn Arnt, Benny Bang-Andersen, Ben Grayson, et al.
EMBO Molecular Medicine|February 22, 2022
Intercepting IRE1 kinase-FMRP signaling prevents atherosclerosis progressionZehra Yildirim, Sabyasachi Baboo, Syed M Hamid, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Heliyon|June 5, 2018
The preparation of benzyl esters using stoichiometric niobium (V) chloride versus niobium grafted SiO<sub>2</sub> catalyst: A comparison studySandro L Barbosa, Camila D Lima, Melina A R Almeida, et al.
Cell Reports|December 3, 2014
FXR1P limits long-term memory, long-lasting synaptic potentiation, and de novo GluA2 translationDenise Cook, Erin Nuro, Emma V Jones, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
American Journal of Medical Genetics. Part A|May 17, 2007
Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardationFrank J Probst, Elizabeth R Roeder, Victoria B Enciso, et al.
Journal of Food Science|March 11, 2022
Polycyclic aromatic hydrocarbons in cachaças packed in bottles of polyethylene terephthalateRafaella H Z Souza, Maria das Graças Cardoso, Ana Maria R Machado, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 17, 2009
In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268)Matthew J Fell, Kenneth W Perry, Julie F Falcone, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT(1A) receptor antagonism/SSRI activities. Part 2Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
Neurobiology of Disease|February 15, 2011
AFQ056, a new mGluR5 antagonist for treatment of fragile X syndromeJosien Levenga, Shigemi Hayashi, Femke M S de Vrij, et al.
The International Journal of Neuropsychopharmacology|June 24, 2010
Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in ratsJorn Arnt, Benny Bang-Andersen, Ben Grayson, et al.
EMBO Molecular Medicine|February 22, 2022
Intercepting IRE1 kinase-FMRP signaling prevents atherosclerosis progressionZehra Yildirim, Sabyasachi Baboo, Syed M Hamid, et al.
Pageof 16